- Published by Stichting OpenAccess Foundation
- Vol. 3 (Supplement) , 31-34
- https://doi.org/10.3233/BEN-1990-31S105
Abstract
Altogether 235 patients with newly diagnosed epilepsy were randomly allocated to treatment with either oxcarbazepine (OXC) or carbamazepine (CBZ) in a double-blind multicentre trial. After a titration phase of 4–8 weeks the optimum individual dose ofKeywords
This publication has 0 references indexed in Scilit: